Benjamin J. Zeskind - 19 Mar 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Benjamin J. Zeskind
Issuer symbol
IMRX
Transactions as of
19 Mar 2024
Net transactions value
+$55,326
Form type
4
Filing time
19 Mar 2024, 18:59:59 UTC
Previous filing
09 Feb 2024
Next filing
07 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $55,326 +20,000 +0.88% $2.77 2,281,852 19 Mar 2024 Direct F1
holding IMRX Class A Common Stock 894,927 19 Mar 2024 See Foonote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.54 to $2.95. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
F2 Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.